The Effectiveness of Tecar Therapy in Management of Calf Muscle Strain Injuries (MS)
25 de abril de 2026 atualizado por: Nabil Mahmoud Ismail Abdel-Aal, Cairo University
this study will be conducted to investigate the effect of TECAR Therapy on quality of landing, healing and Function in patient with Calf Muscle Strain.
Visão geral do estudo
Status
Ainda não está recrutando
Condições
Intervenção / Tratamento
Descrição detalhada
Calf muscle strain is one of the most common muscle injuries in high-performance athletes and contributes to substantial player downtime because of its high mean time to return to sport and occurrence during critical periods in the competitive season.
Published reports on lower-body muscle strain have provided frequent updates on the rehabilitation of high-profile muscle groups, such as the hamstring muscles, and improvements to calf strain management are seldom discussed despite the prevalence of these injuries in competitive sports.
In this article, we discuss the diagnosis, treatment, outcomes, risk factors, and prevention of calf muscle strain in athletes.Transfer of Electricity-Capacitive and Resistive (Tecar) therapy is considered a special form of energy that uses frequencies between 300 KHz and 1 MHz and is characterized as a non-invasive high-frequency energy that awakens the body's natural ability to self-regenerate.
Thus, it promotes the natural physiological processes of the tissue metabolically, transferring energy without introducing radiation from the external environment.
TECAR therapy stands out as a promising yet underexplored modality.
Its mechanism of action-utilizing both capacitive and resistive energy transfer-suggests a novel approach to addressing musculoskeletal injuries and pain.
While preliminary studies and clinical applications hint at its potential advantages, such as improved tissue healing and pain relief, a comprehensive evaluation of the existing research is necessary to fully understand the role of TECAR therapy in rehabilitation
Tipo de estudo
Intervencional
Inscrição (Estimado)
60
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Contato de estudo
- Nome: Nabil Abdel-Aal, professor
- Número de telefone: 01200133613
- E-mail: nabil.mahmoud@cu.edu.eg
Estude backup de contato
- Nome: Hossam Mostafa, master
- Número de telefone: 01092727746
- E-mail: h.elshatory@gmail.com
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
Aceita Voluntários Saudáveis
Não
Descrição
Inclusion Criteria:
- Aged between 16-39 years of age.
- not having suffered leg injuries in the past 6 months.
- not having suffered a triceps sural rupture in the past two years.
- be diagnosed with latent MTPs in the gastric-soleus complex through manual therapy in the dominant side.
- Presence of Calf muscles Strain evaluated by Ultrasonography.
- Athlete willing and able to participate in an exercise program safely.
- The radiologist also assessed whether the tendon ends could be reduced in passive plantar flexion of the ankle joint with the knee extended.
- Athlete BMI from 18.5 to 24.9 kg / m2
Exclusion Criteria:
- connective tissue pathology.
- lymphatic disorders (lymphadenopathy).
- Skin injuries (open wounds, infection, psoriasis, tattoos, hematoma).
- peripheral neuropathies.
- previous fractures.
- previous lower limb surgeries (in the past 12 months).
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: TECAR therapy
Thirty patients will receive TECAR therapy combined with conventional treatment three times per week for 12 weeks.
|
The TECAR intervention was administered to the calf muscle using the Zimmer devicein capacitive (CAP) mode for a duration of 20 min.
The therapy was applied with the signal at a variable power with a maximum of 300 W. The frequency used was 500 kHz with an intensity of 40%.
The intervention was standardized to a distal-to-proximal stroking rhythm with moderate pressure.
For the TECAR intervention, the capacitive (CAP) mode at 500 kHz with 40% intensity and a maximum power of 300 W was chosen to optimize deep tissue heating and promote local blood flow and tissue recovery.
The 20 min duration reflects protocols commonly used in therapeutic settings for muscle recovery and rehabilitation plus conventional therapy
the patients will receive stretching exercises of the gastrocnemius (straight leg) and soleus (bended knee), eccentric exercises for calf muscles, plus plyometric exercises.
|
|
Comparador Ativo: conventional treatment
Thirty patients will receive conventional treatment three times per week for 12 weeks.
|
the patients will receive stretching exercises of the gastrocnemius (straight leg) and soleus (bended knee), eccentric exercises for calf muscles, plus plyometric exercises.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
size of injury
Prazo: up to 12 weeks
|
ultrasonography device will be used to assess size of injury
|
up to 12 weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
landing error score system
Prazo: up to 12 weeks
|
Landing Error Scoring System is a clinical tool used to assess jump-landing mechanics for the video from my jumb land aplication .
the feet, ankle, knees, hip, trunk, shoulder, neck and head posture is assessed through the video.
it is a 17-item .
According to the performance sheet, the questions 1-15 are Yes/No questions that are rated as 0 or 1.
The questions 16 are rated as 0, 1, and 2; 0 = soft, 1= average and 2= stiff.
the question 17 are rated as 0,1,2; 0= excellent,1 average and 2= poor, so the total score ranges from zero to 19.
A higher score indicates poor technique in landing from a jump; a lower score indicates better jump-landing technique.
the score are categorized as excellent which less than 4, good score more than four and less than or equal 5, moderate score less than four and poor more than six
|
up to 12 weeks
|
|
jump height
Prazo: up to 12 weeks
|
The vertical jump test was performed as a one-legged counter movement jump (CMJ).
Starting position was in an upright position with the hands placed behind the back.
The subjects quickly bent the knee as much as desired and then immediately jumped upward attempting to maximize the height jumped.
The subjects performed three maximal approved trials for each leg, starting with the right and alternating between the right and the left leg.
However, if the subject increased hop performance in all three jumps, additional jumps were performed until no increase was seen.
The best jump height for each leg was used for data analysis.
|
up to 12 weeks
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Estimado)
1 de maio de 2026
Conclusão Primária (Estimado)
1 de dezembro de 2026
Conclusão do estudo (Estimado)
1 de dezembro de 2026
Datas de inscrição no estudo
Enviado pela primeira vez
25 de abril de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
25 de abril de 2026
Primeira postagem (Real)
1 de maio de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
1 de maio de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
25 de abril de 2026
Última verificação
1 de abril de 2026
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- P.T.REC/012/006406
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .